 |
Video: What is a Stock Split?
|
 |
23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. Co. operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. According to our ME split history records, 23andMe Holding has had 1 split. | |
 |

23andMe Holding (ME) has 1 split in our ME split history database. The split for ME took place on October 16, 2024. This was a 1 for 20 reverse split, meaning for each 20 shares of ME owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as 23andMe Holding conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ME split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into 23andMe Holding shares, starting with a $10,000 purchase of ME, presented on a split-history-adjusted basis factoring in the complete ME split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/05/2021 |
|
End date: |
02/10/2025 |
|
Start price/share: |
$228.00 |
|
End price/share: |
$2.57 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.87% |
|
Average Annual Total Return: |
-66.50% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$112.73 |
|
Years: |
4.10 |
|
|
 |
Date |
Ratio |
10/16/2024 | 1 for 20 |
|
 |